Buti M - Search Results

1

Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.

Hsu YC, Yeh ML, Wong GL, Chen CH, Peng CY, Buti M, Enomoto M, Xie Q, Trinh H, Preda C, Liu L, Cheung KS, Yeo YH, Hoang J, Huang CF, Riveiro-Barciela M, Kozuka R, Istratescu D, Tsai PC, Accarino EV, Lee DH, Wu JL, Huang JF, Dai CY, Cheung R, Chuang WL, Yuen MF, Wong VW, Yu ML, Nguyen MH. Hsu YC, et al. Among authors: buti m. J Infect Dis. 2021 Dec 1;224(11):1890-1899. doi: 10.1093/infdis/jiab241. J Infect Dis. 2021. PMID: 33999179 Clinical Trial.

2

Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis.

Buti M, Esteban R, Español MT, Malagelada A, Jardi R, Rodriguez-Frias F, Roget M, Guardia J. Buti M, et al. J Infect Dis. 1991 Jun;163(6):1351-3. doi: 10.1093/infdis/163.6.1351. J Infect Dis. 1991. PMID: 1674749

3

Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine.

Buti M, Jardi R, Cotrina M, Rodriguez-Frias F, Esteban R, Guardia J. Buti M, et al. J Hepatol. 1998 Mar;28(3):510-3. doi: 10.1016/s0168-8278(98)80327-9. J Hepatol. 1998. PMID: 9551691

4

Quantification of serum hepatitis C virus RNA with daily or standard interferon doses plus ribavirin in nonresponder patients with chronic hepatitis C.

Buti M, Olive G, Stalgis C, Esteban R, Guardi J. Buti M, et al. Dig Dis Sci. 2000 Apr;45(4):685-9. doi: 10.1023/a:1005479207106. Dig Dis Sci. 2000. PMID: 10759235

5

[Prevalence and incidence of hepatitis A in patients with hepatitis B and C].

Olivé G, Buti M, Ignacio Esteban J, Cotrina M, Esteban R, Guardia J. Olivé G, et al. Among authors: buti m. Med Clin (Barc). 2000 Sep 9;115(7):254-5. doi: 10.1016/s0025-7753(00)71525-9. Med Clin (Barc). 2000. PMID: 11013148 Spanish.

6

Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B.

Buti M, Sánchez F, Cotrina M, Jardi R, Rodríguez F, Esteban R, Guardia J. Buti M, et al. J Infect Dis. 2001 Apr 15;183(8):1277-80. doi: 10.1086/319677. Epub 2001 Mar 13. J Infect Dis. 2001. PMID: 11262212 Clinical Trial.

7

High-Dose interferon-alpha2b plus ribavirin for retreatment of interferon-nonresponsive patients infected with genotype 1 hepatitis C virus.

Buti M, Morral S, Sanchez F, Martell M, Stalgis C, Esteban R. Buti M, et al. Dig Dis Sci. 2001 Nov;46(11):2396-400. doi: 10.1023/a:1012355332052. Dig Dis Sci. 2001. PMID: 11713942

8

Hepatitis E virus epidemiology in industrialized countries.

Clemente-Casares P, Pina S, Buti M, Jardi R, MartIn M, Bofill-Mas S, Girones R. Clemente-Casares P, et al. Among authors: buti m. Emerg Infect Dis. 2003 Apr;9(4):448-54. doi: 10.3201/eid0904.020351. Emerg Infect Dis. 2003. PMID: 12702225 Free PMC article.

9

Drugs in development for hepatitis B.

Buti M, Esteban R. Buti M, et al. Drugs. 2005;65(11):1451-60. doi: 10.2165/00003495-200565110-00001. Drugs. 2005. PMID: 16033287 Review.

10

Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.

Rodriguez-Frias F, Jardi R, Buti M, Schaper M, Hermosilla E, Valdes A, Allende H, Martell M, Esteban R, Guardia J. Rodriguez-Frias F, et al. Among authors: buti m. J Viral Hepat. 2006 May;13(5):343-50. doi: 10.1111/j.1365-2893.2005.00691.x. J Viral Hepat. 2006. PMID: 16637866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

636 results

Search Page